Microglia contribute to mammary tumor‐induced neuroinflammation in a female mouse model
The FASEB Journal · 31.01.2024 · 38 (2)
DOI: 10.1096/fj.202301580rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 18.01.2024. Verfasst von Lindsay D Strehle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Behavioral Medicine Research, Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Mammary Neoplasms, Animal, Breast Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Following diagnosis but before treatment, up to 30% of breast cancer patients report behavioral side effects (e.g., anxiety, depression, memory impairment). Our rodent mammary tumor model recapitulates aspects of these behavioral sequelae, as well as elevated circulating and brain inflammatory mediators. Neuroinflammation is a proposed mechanism underlying the etiology of mood disorders and cognitive deficits, and therefore may be contributing to tumor‐associated behavioral side effects. The cellular mechanisms by which tumor‐induced neuroinflammation occurs remain unknown, making targeted treatment approaches inaccessible. Here, we tested the hypotheses that microglia are the primary cells driving tumor‐induced neuroinflammation and behavioral side effects. Young adult female BALB/c mice were induced with a 67NR mammary tumor; tumor‐free controls underwent a sham surgery. Mammary tumors increased IBA1 + and GFAP + staining in the amygdala and hippocampus relative to tumor‐free controls. However, tumors did not alter gene expression of Percoll‐enriched microglia isolated from the whole brain. While cognitive, social, and anhedonia‐like behaviors were not altered in tumor‐bearing mice, tumors increased central tendency in the open‐field test; microglia depletion did not reverse this effect. Brain region RT‐qPCR data indicated that microglia depletion attenuated tumor‐induced elevations of neuroinflammatory gene expression in a region‐ and mediator‐specific manner. These results indicate a causal role of microglia in tumor‐induced neuroinflammation. This research advances our understanding of the cellular mechanisms underlying tumor‐induced neuroinflammation in order to understand how brain responses (e.g., behavior) may be altered with subsequent cancer‐related immune challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Behavioral Medicine Research, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
- Department of Neuroscience, Ohio State University, Columbus, Ohio, USA.
- Department of Psychiatry and Behavioral Health, Ohio State University, Columbus, Ohio, USA.
ORCID-Profile: Lindsay D Strehle, Lauren D Otto-Dobos, Corena V Grant, Erica R Glasper, Leah M Pyter
Förderung
- NCI NIH HHS
Zitieren
APA
Strehle, L. D., Otto-Dobos, L. D., Grant, C. V., Glasper, E. R., & Pyter, L. M. (2024). Microglia contribute to mammary tumor‐induced neuroinflammation in a female mouse model. The FASEB Journal, 38(2). https://doi.org/10.1096/fj.202301580rr
Vancouver
Strehle LD, Otto-Dobos LD, Grant CV, Glasper ER, Pyter LM. Microglia contribute to mammary tumor‐induced neuroinflammation in a female mouse model. The FASEB Journal. 2024;38(2). doi:10.1096/fj.202301580rr
BibTeX
@article{Strehle2024,
author = {Strehle, Lindsay D and Otto-Dobos, Lauren D and Grant, Corena V and Glasper, Erica R and Pyter, Leah M},
title = {Microglia contribute to mammary tumor‐induced neuroinflammation in a female mouse model},
journal = {The FASEB Journal},
year = {2024},
volume = {38},
number = {2},
doi = {10.1096/fj.202301580rr}
}
EUVIMED